• Products
  • Catalogs
  • News & Trends
  • Exhibitions

Dilatation catheter Legflow RX®, Legflow OTW® series
peripheralballoondrug eluting

dilatation catheter
dilatation catheter
dilatation catheter
dilatation catheter
dilatation catheter
Add to favorites
Compare this product


Area of the body
balloon, drug eluting


The best option for SFA/popliteal de novo and restenotic lesions. Treating peripheral artery disease (PAD) in the superficial femoral artery (SFA) is a difficult challenge. The anatomy is very dynamic and contains complex lesions, but also patient comorbidities such as diabetes require the clinically most-effective therapy. The new LEGFLOW Paclitaxel-releasing peripheral balloon dilatation catheter provides a clinically most successful treatment of peripheral artery disease, and ensures a long-term vessel patency. The new treatment of BTK lesions and critical limb ischemia! LEGFLOW shows promising early clinical study results. The rate of recurrent stenosis after PTA and stenting is higher in the below-the-knee area than in femoropopliteal procedures. The absence of metal struts makes the LEGFLOW balloon dilatation suitable for treating long lesions, especially in small diameter vessels and areas in which flexion and compression of the stent may occur and result in stent fractures, particularly in the below-the-knee area. Thanks to the new stable ‘SAFEPAX’ PTX coating technology, the treatment of critical limb ischemia patients appears as safe as POBA angioplasty. High coating stability and minmal particulate loss. Perform precedures with no need to rush. The lowest PTX serum concentration on the market. LEGFLOW ‘SAFEPAX’ coating is a step beyond contemporary first and second generation DCB coatings which had to compromise on vulnerable balloon coating mixtures out of a high water soluble drug excipient with relatively large PTX crystals. Minimizing the risk of microembolization.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.